Home > Resources > Whitepapers > White Paper Biotechnology and Blockchain

White Paper Biotechnology and Blockchain

January 8, 2019

Biotechnology is developing rapidly and even though it seemed out of focus of investors for some time, it appears to be coming back at the moment. The German government only recently launched a new bio agenda, putting forward a strong program for the next step in the biotech development. With a focus on the newest developments, biotechnology seems to be on the rise again. New themes such as “value based medicine” are bringing new movements that might enable another major biotech phase. The believe that biotechnology will be the next big technology after digitalization raises questions and makes the industry an interesting field for research from different perspectives.

Spotlight

Vipergen ApS

Vipergen is commercializing two proprietary technologies: 1) YoctoReactor® technology for the creation of DNA-encoded small-molecule libraries (drug-like, small molecule libraries with millions of members in a single tube format), and 2) Binder Trap Enrichment® for interrogation of DNA-encoded small-molecule libraries.

OTHER WHITEPAPERS

Your Ultimate Guide to CMC Testing Support for Gene and Cell Therapy

whitePaper | December 6, 2022

The development of Advanced Therapy Medicinal Products such as gene and cell therapy products, has made significant progress in the treatment of many diseases, including cancer, genetic, and autoimmune disorders.

Establishment of the basidiomycete Fomes fomentarius for the production of composite materials

whitePaper | February 24, 2022

Filamentous fungi of the phylum Basidiomycota are considered as an attractive source for the biotech‑ nological production of composite materials. The ability of many basidiomycetes to accept residual lignocellulosic plant biomass from agriculture and forestry.